Catalogo dei prodotti della ricerca

MECO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.419
EU - Europa 1.142
AS - Asia 556
AF - Africa 28
SA - Sud America 21
OC - Oceania 1
Totale 6.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.402
IT - Italia 397
SG - Singapore 237
SE - Svezia 199
UA - Ucraina 188
IN - India 178
CN - Cina 138
FI - Finlandia 123
DE - Germania 70
BG - Bulgaria 30
RU - Federazione Russa 28
GB - Regno Unito 27
AR - Argentina 20
TG - Togo 20
IE - Irlanda 17
BE - Belgio 15
CA - Canada 15
AT - Austria 10
FR - Francia 8
ZA - Sudafrica 7
CH - Svizzera 6
RO - Romania 6
AL - Albania 4
LT - Lituania 3
MK - Macedonia 3
NL - Olanda 3
MX - Messico 2
NO - Norvegia 2
AU - Australia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
ID - Indonesia 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
SC - Seychelles 1
Totale 6.167
Salva come PNG Salva come JPEG
Città #
Fairfield 723
Woodbridge 428
Chandler 303
Ashburn 299
Houston 298
Seattle 280
Cambridge 221
Wilmington 214
Ann Arbor 182
Singapore 171
Santa Clara 158
Rome 120
Princeton 106
Plano 96
San Paolo di Civitate 95
Dearborn 84
Jacksonville 80
Beijing 77
Lawrence 76
Boston 54
San Diego 47
Millbury 41
Andover 35
Helsinki 30
Sofia 30
Norwalk 28
Boardman 22
Federal 20
Lomé 20
Dublin 17
Falls Church 16
Brussels 14
Fremont 14
Hefei 13
Milan 13
Toronto 12
Moscow 11
Vienna 10
Des Moines 9
Falkenstein 9
Bühl 8
Catania 6
Dallas 6
Kunming 6
Muizenberg 6
Nanjing 6
San Mateo 6
Cerveteri 5
Grafing 5
Mannheim 5
Bern 4
Jinan 4
Lanuvio 4
Los Angeles 4
New York 4
Vlorë 4
Flero 3
Frankfurt am Main 3
Genova 3
Guangzhou 3
London 3
Ottawa 3
Putney 3
San Francisco 3
Shanghai 3
Skopje 3
Southend 3
Zhengzhou 3
Auburn Hills 2
Barre 2
Bassano del Grappa 2
Casperia 2
Cattolica 2
Ciampino 2
Clearwater 2
Desio 2
Fossano 2
Lappeenranta 2
Las Vegas 2
Leawood 2
Lugano 2
Marsico Nuovo 2
Mexico City 2
Modena 2
Oslo 2
Padova 2
Parma 2
Pavullo nel Frignano 2
Philadelphia 2
Pisa 2
Redmond 2
San Secondo Parmense 2
Serra 2
Syracuse 2
Westminster 2
Agrate Brianza 1
Ameglia 1
Arzano 1
Avellino 1
Baotou 1
Totale 4.654
Salva come PNG Salva come JPEG
Nome #
Capacità diagnostica dei riflessi trigemino-cervicali nella diagnosi differenziale tra la paralisi sopranucleare progressiva e la malattia di Parkinson 214
A case control study on Alzheimer's disease and exposure to anesthesia 111
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 108
Fast complex arm movements in Parkinson's disease. 100
L acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine 99
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 99
PARK11 is not linked with Parkinson's disease in European families 98
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study 95
Hedonistic homeostatic dysregulation in Parkinson's disease: a short screening questionnaire 89
Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment 89
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users 89
Genetic architecture of MAPT gene region in Parkinson disease subtypes 88
Origin of the mutations in the parkin gene in Europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects 88
The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients 87
PARK6-Linked Parkinsonism Occurs in Several European Families 85
DJ-1(Park-7), a novel gene for autosomal recessive, early onset parkinsonism 83
Levetiracetam in L-dopa-induced dyskinesia 82
Excessive daytime sleepiness in de novo and treated Parkinson's disease. 82
DOPAMINE AND MIGRAINE:DOES PARKINSON'S DISEASE MODIFY MIGRAINE COURSE? 81
Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset 78
A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force. 78
Mirtazapine in l-dopa induced dyskinesias 77
Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study 76
GENETIC POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IS NOT ASSOCIATED WITH THE DEVELOPMENT OF PARKINSON’S DISEASE AND OF L-DOPA INDUCED ADVERSE EFFECTS 75
Case-control study of multiple system atrophy 75
PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology. 75
Combined Serotonin 5-HT2 and Dopamine D2 antagonism in Schizophrenia: clinical, extrapyramidal and neuroendocrine response in a preliminary study with Risperidone (R 64766) 75
Intercepting Parkinson disease non-motor subtypes. a proof-of-principle study in a clinical setting 74
Novel parkin mutations detected in patients with early-onset Parkinson's disease 74
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 73
Pain Week. Progetto formativo teorico-pratico per le Facoltà di Medicina, a supporto della legge 38/2010. 73
Twenty-four-hour heart rate variability to assess autonomic function in Parkinson's disease. 73
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. 73
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 72
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease 72
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease 71
Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes 70
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease 70
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. 70
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression 69
Red flags for multiple system atrophy 68
Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations. 68
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease. 68
Excessive Daytime Sleepiness in Multiple System Atrophy (SLEEMSA Study) 67
Health-related quality of life in multiple system atrophy 67
Belly dance syndrome due to spinal myoclonus 66
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease 65
Donepezil in the treatment of progressive supranuclear palsy. 65
Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease? 65
Levetiracetam in tardive dyskinesia 64
A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type 63
Hedonic tone and its mood and cognitive correlates in Parkinson's disease. 62
The European Multiple System Atrophy-Study Group (EMSA-SG) 62
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. 62
Reversible Pisa syndrome associated to subdural haematoma: case-report. 61
The role of thymus in multiple sclerosis. 60
Transcranial sonographic findings in Wilson disease. 60
Excessive daytime somnolence in Parkinson's disease.Follow-up after 1 year of treatment 60
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease 60
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 60
Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: A pilot study 60
High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians. 60
TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease 59
How much phenotypic variation can be attribuited to parkin genotype? 58
The PRIAMO study: background, methods and recruitment 57
Increased expression of dopamine receptors on luymphocytes in Parkinson's disease 56
Sexual dysfunction in Parkinson's disease 56
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes 55
Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. 54
Can COMT inhibitors improve cognitive functions in patients with Parkinson's disease? 54
Autosomal recessive esrly onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7 50
Genome-wide dcsn linkage analysis for Parkinso's disease:the European genetics study of parkinson's disease 49
Lack of association between IL-1beta, TNF-alfa, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort 49
Bladder and voiding dysfunction in Parkinson's disease 48
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. 47
Lack of association between genetic polymorphism of angiotensin-converting enzyme and parkinson's disease. 46
HEART RATE VARIABILITY IN PARKINSON DISEASE PATIENTS TREATED WITH TOLCAPONE 45
biological effects of the PINK 1 c.1366>T mutation:implications in Parkinson's disease pathogenesis. 45
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment. Italian multicentre survey of 905 patients with longterm follow-up 45
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease 45
A frequent LRRK2 gene mutation associated with autosomal dominat Parkinson's disease 44
Posterior reversible encephalopathy syndrome due to ozone-oxygen therapy. 44
Donezepil in the treatment of hallucinations and delusions in Parkinson's disease 44
MUTATIONS IN THE DJ-1 GENE ASSOCIATED WITH AUTOSOMAL RECESSIVE EARLY-PARKINSONISM 43
The natural history of multiple system atrophy: a prospective European cohort study. 43
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 43
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 42
ON BEHALF OF THE EMSA‐SG. PRESENTATION, DIAGNOSIS, AND MANAGEMENT OF MULTIPLE SYSTEM ATROPHY IN EUROPE: FINAL ANALYSIS OF THE EUROPEAN MULTIPLE SYSTEM ATROPHY REGISTRY. 41
Frontal lobe dysfunction in essential tremor: A preliminary study 36
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. 26
Is genetic polymorphism of Angiotensin-converting enzyme associated with the development of L-DOPA induced adverse effect? 25
Impulse control disorders in Parkinson's disease: the psychophysiological evaluation of cognitive functions 25
Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses. 24
null 24
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. 23
Tha tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in italian cases 19
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. 13
Totale 6.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020779 0 0 0 0 0 0 212 185 159 112 77 34
2020/2021437 53 61 26 55 10 46 8 43 46 48 31 10
2021/20221.017 4 87 110 26 118 14 33 105 66 83 178 193
2022/20231.060 188 279 65 97 117 101 18 67 81 21 23 3
2023/2024369 36 65 12 43 20 38 2 29 4 47 30 43
2024/2025435 43 82 35 14 104 155 2 0 0 0 0 0
Totale 6.280